Our Research Publications
Updated November 2023
Pagination
- Page 1
- Next page
Title | Authors | Year | Journal | Link to Article | Intended Audience Sort ascending | Purpose |
---|---|---|---|---|---|---|
Factor XIa-specific aptamers | Sheffield WP, Donkor DA | 2017 | European Patent Office | View Factor XIa-specific aptamers | Industry | New or improved product or process |
The Market in Noninvasive Prenatal Tests and the Message to Consumers: Exploring Responsibility | Holloway K, Simms N, Hayeems RZ, Miller FA | 2022 | Hastings Cent Rep | View The Market in Noninvasive Prenatal Tests and the Message to Consumers: Exploring Responsibility | Regulators | Ethical, legal and social implications research |
Bacterial growth in red blood cell units exposed to uncontrolled temperatures: challenging the 30-minute rule | Ramirez-Arcos S, Perkins H, Kou Y, Mastronardi C, Kumaran D, Taha M, Yi QL, McLaughlin N, Kahwash E, Lin Y, Acker J | 2013 | Vox Sang | View Bacterial growth in red blood cell units exposed to uncontrolled temperatures: challenging the 30-minute rule | Regulators | New or improved product or process |
Evaluating the 4-hour and 30-minute rules: effects of room temperature exposure on red blood cell quality and bacterial growth | Ramirez-Arcos S, Mastronardi C, Perkins H, Kou Y, Turner T, Mastronardi E, Hansen A, Yi QL, McLaughlin N, Kahwash E, Lin Y, Acker J | 2013 | Transfusion | View Evaluating the 4-hour and 30-minute rules: effects of room temperature exposure on red blood cell quality and bacterial growth | Regulators | New or improved product or process |
Early warning and rapid public health response to prevent COVID-19 outbreaks in long-term care facilities (LTCF) by monitoring SARS-CoV-2 RNA in LTCF site-specific sewage samples and assessment of antibodies response in this population: prospective study protocol | Lee BE, Sikora C, Faulder D, Risling E, Little LA, Qiu Y, Gao T, Bulat R, Craik S, Hrudey SE, Ohinmaa A, Estabrooks CA, Gingras A-C, Charlton C, Kim J, Wood H, Robinson A, Kanji JN, Zelyas N, O’Brien SF, Drews S, Pang X-L | 2021 | BMJ Open | View Early warning and rapid public health response to prevent COVID-19 outbreaks in long-term care facilities (LTCF) by monitoring SARS-CoV-2 RNA in LTCF site-specific sewage samples and assessment of antibodies response in this population: prospective study protocol | Regulators | New or improved product or process |
ResearchUnit: Whole blood: longer holding times before leukoreduction may be a safe to explore option | Chen ZY | 2022 | Blood.ca website | View ResearchUnit: Whole blood: longer holding times before leukoreduction may be a safe to explore option | Regulators | New or improved product or process |
Concentré de recherche: Le risque de transmission du VIH est demeuré inchangé avec l’élargissement des critères d’admissibilité aux hommes gais, bisexuels et autres hommes ayant des rapports sexuels avec d’autres hommes | Walsh G | 2022 | Blood.ca website | View Concentré de recherche: Le risque de transmission du VIH est demeuré inchangé avec l’élargissement des critères d’admissibilité aux hommes gais, bisexuels et autres hommes ayant des rapports sexuels avec d’autres hommes | Regulators | MSM research |
ResearchUnit: Risk of HIV did not change with expanding eligibility criteria for gay, bisexual and other men who have sex with men | Walsh G | 2022 | Blood.ca website | View ResearchUnit: Risk of HIV did not change with expanding eligibility criteria for gay, bisexual and other men who have sex with men | Regulators | MSM research |
HIV incidence and compliance with deferral criteria over three progressively shorter time deferrals for men who have sex with men in Canada | Caffrey N, Goldman M, Osmond L, Yi Q-L, Fan W, O'Brien SF | 2022 | Transfusion | View HIV incidence and compliance with deferral criteria over three progressively shorter time deferrals for men who have sex with men in Canada | Regulators | MSM research |
Regulatory decisions pertaining to aprotinin may be putting patients at risk | Hebert PC, Fergusson DA, Hutton B, Mazer CD, Fremes S, Blajchman M, MacAdams C, Wells G, Robblee J, Bussieres J, Teoh K | 2014 | CMAJ | View Regulatory decisions pertaining to aprotinin may be putting patients at risk | Regulators | Other |
Blood shortages planning in Canada: The National Emergency Blood Management Committee experience during the first 6 months of the COVID-19 pandemic | Prokopchuk-Gauk O, Petraszko T, Nahirniak S, Doncaster C, Levy I | 2021 | Transfusion | View Blood shortages planning in Canada: The National Emergency Blood Management Committee experience during the first 6 months of the COVID-19 pandemic | Regulators | Benchmarking and standard setting |
Validation of administrative database codes for acute kidney injury in kidney transplant recipients | Molnar AO, van Walraven C, McArthur E, Fergusson D, Garg AX, Knoll G | 2016 | Can J Kidney Health Dis | View Validation of administrative database codes for acute kidney injury in kidney transplant recipients | Regulators | New or improved product or process |
Exploring the reasons for low pertussis vaccine effectiveness in Ontario, Canada, 2006–2008: a Canadian Immunization Research Network study | Hughes SL, Kwong JC, Schwartz KL, Chen C, Johnson C, Li Y, Marchand-Austin A, Bolotin S, Jamieson FB, Drews SJ, Russell ML, Svenson LW, Mahmud SM, Crowcroft NS | 2022 | Can J Public Health | View Exploring the reasons for low pertussis vaccine effectiveness in Ontario, Canada, 2006–2008: a Canadian Immunization Research Network study | Regulators | Clinical research |
Enlargement of the WHO international repository for platelet transfusion-relevant bacteria reference strains | Spindler-Raffel E, Benjamin RJ, McDonald CP, Ramirez-Arcos S, Aplin K, Bekeredjian-Ding I, de Korte D, Gabriel C, Gathof B, Hanschmann KM, Hourfar K, Ingram C, Jacobs MR, Keil SD, Kou Y, Lambrecht B, Marcelis J, Mukhtar Z, Nagumo H, Niekerk T, Rojo J, Marschner S, Satake M, Seltsam A, Seifried E, Sharafat S, Stormer M, Sussner S, Wagner SJ, Yomtovian R | 2017 | Vox Sang | View Enlargement of the WHO international repository for platelet transfusion-relevant bacteria reference strains | Regulators | Benchmarking and standard setting |
Bacterial contamination in platelet concentrates | Pietersz RNI, Reesink HW, Panzer S, Oknaian S, Kuperman S, Gabriel C, Rapaille A, Lambermont M, Deneys V, Sondag D, Ramirez-Arcos S, Goldman M, Delage G, Bernier F, Germain M, Vuk T, Georgsen J, Morel P, Naegelen C, Bardiaux L, Cazenave JP, Dreier J, Vollmer T, Knabbe C, Seifried E, Hourfar K, Lin CK, Spreafico M, Raffaele L, Berzuini A, Prati D, Satake M, de Korte D, van der Meer PF, Kerkhoffs JL, Blanco L, Kjeldsen-Kragh J, Svard-Nilsson AM, McDonald CP, Symonds I, Moule R, Brailsford S, Yomtovian R, Jacobs MR | 2014 | Vox Sang | View Bacterial contamination in platelet concentrates | Blood operators | Benchmarking and standard setting |
Vox Sanguinis international forum on provision of granulocytes for transfusion and their clinical use: summary | Morton S, Stanworth S, Lozano M, Harrison S, Hong F, Dennington P, McQuilten Z, Worel N, Compernolle V, Kutner J, Yokoyama A, Nahirniak S, Germain M, Hume H, Robitaille N, Wilson A, Tinmouth A, Massey E, Boulat C, Woimant G, Tiberghien P, Schulze T, Bux J, Pierelli L, Ballester C, Netelenbos T, West K, Conry-Cantilena C, Eder A, Haley N, Yazer M, Triulzi D | 2017 | Vox Sang | View Vox Sanguinis international forum on provision of granulocytes for transfusion and their clinical use: summary | Blood operators | Clinical research |
Alternatives in blood operations when choosing non-DEHP bags | van der Meer PF, Devine DV, on behalf of the BEST Collaborative | 2017 | Vox Sang | View Alternatives in blood operations when choosing non-DEHP bags | Blood operators | New or improved product or process |
Determining staffing requirements for blood donor clinics: the Canadian Blood Services experience | Blake JT, Shimla S | 2014 | Transfusion | View Determining staffing requirements for blood donor clinics: the Canadian Blood Services experience | Blood operators | New or improved product or process |
Donor criteria for men who have sex with men: a Canadian perspective | Goldman M, Lapierre D, Lemay L, Devine D, Sher G | 2014 | Transfusion | View Donor criteria for men who have sex with men: a Canadian perspective | Blood operators | Benchmarking and standard setting |
Evaluation of the sterility testing process of hematopoietic stem cells at Canadian Blood Services | Mastronardi C, Yang L, Halpenny M, Toye B, Ramirez-Arcos S | 2012 | Transfusion | View Evaluation of the sterility testing process of hematopoietic stem cells at Canadian Blood Services | Blood operators | New or improved product or process |
Pathogen reduction technologies: The pros and cons for platelet transfusion | Magron A, Laugier J, Provost P, Boilard E | 2018 | Platelets | View Pathogen reduction technologies: The pros and cons for platelet transfusion | Blood operators | Basic research |
Using simulation for strategic blood supply chain design in the Canadian prairies | Blake J, McTaggart K | 2016 | Proceedings of the 6th International Conference on SIMULTECH | View Using simulation for strategic blood supply chain design in the Canadian prairies | Blood operators | New or improved product or process |
An international comparison of anti-SARS-COV-2 assays used for seroprevalence surveys from blood component providers | Lewin A, Drews SJ, Lieshout-Krikke R, Erikstrup C, Saeed S, Fady H, Uzicanin S, Custer B, O’Brien SF, the Surveillance Risk Assessment Policy tVS-gotI, Transfusion Transmitted Infectious Diseases Working Party | 2021 | Vox Sang | View An international comparison of anti-SARS-COV-2 assays used for seroprevalence surveys from blood component providers | Blood operators | Benchmarking and standard setting |
The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study | Cho JH, Rajbhandary S, van Buren NL, Fung MK, Al-Ghafry M, Fridey JL, Dy BA, Ziman A, Schreiber GB, Gammon RR, Reik R, Stubbs JR, van Buskirk CM, Kamel H, Townsend MJ, Zeller MP, Gottschall JL | 2021 | Transfusion | View The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study | Blood operators | Benchmarking and standard setting |
HIV residual risk in Canada for apheresis source plasma donation without deferral for men who have sex with men | Aubé E, Lewin A, O'Brien SF, Grégoire Y, Pillonel J, Steele WR, Custer B, Davison KL, Germain M, Seed CR, Camirand Lemyre F, the Surveillance RA, Policy Subgroup of the ISBT Transfusion Transmitted Infectious Diseases Working Party | 2022 | Vox Sang | View HIV residual risk in Canada for apheresis source plasma donation without deferral for men who have sex with men | Blood operators | MSM research |
Surveillance report | O'Brien SF | 2022 | Blood.ca website | View Surveillance report | Blood operators | Benchmarking and standard setting |
Changing the deferral for men who have sex with men - an improved model to estimate HIV residual risk | Davison KL, Gregoire Y, Germain M, Custer B, O'Brien SF, Steele WR, Pillonel J, Seed CR | 2019 | Vox Sang | View Changing the deferral for men who have sex with men - an improved model to estimate HIV residual risk | Blood operators | New or improved product or process |
Impacts of COVID-19 and elective surgery cancellations on platelet supply and utilization in the Canadian Province of British Columbia | Shopsowitz KE, Lim C, Shih AW, Fishbane N, Berry BR, Bigham M, Petraszko T, Trudeau J, Wyatt M, Yan MTS, Morrison D | 2022 | Vox Sang | View Impacts of COVID-19 and elective surgery cancellations on platelet supply and utilization in the Canadian Province of British Columbia | Blood operators | Benchmarking and standard setting |
Climate change and parasitic risk to the blood supply | Drews SJ, Wendel S, Leiby DA, Tonnetti L, Ushiro-Lumb I, O'Brien SF, Lieshout-Krikke RW, Bloch EM, the International Society of Blood Transfusion Working Party Parasite Subgroup | 2023 | Transfusion | View Climate change and parasitic risk to the blood supply | Blood operators | Clinical research |
Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk | Jenkins C, Ramirez-Arcos S, Goldman M, Devine DV | 2011 | Transfusion | View Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk | Blood operators | New or improved product or process |
Introducing the red cell storage lesion | Chen D, Serrano K, Devine DV | 2016 | ISBT Sci Ser | View Introducing the red cell storage lesion | Blood operators | Basic research |
The Platelet Storage Lesion | Devine DV, Serrano K | 2010 | Clin Lab Med | View The Platelet Storage Lesion | Blood operators | Other |
Understanding iron depletion and overload in blood donors | O'Brien SF, Goldman M | 2017 | ISBT Sci Ser | View Understanding iron depletion and overload in blood donors | Blood operators | Clinical research |
Safety of blood donation by individuals over age 70 and their contribution to the blood supply in five developed countries: a BEST Collaborative group study | Goldman M, Germain M, Gregoire Y, Vassallo RR, Kamel H, Bravo M, Irving DO, Di Angelantonio E, Steele WR, O'Brien SF, for the Biomedical Excellence for Safer Transfusion Collaborative (BEST) Investigators | 2019 | Transfusion | View Safety of blood donation by individuals over age 70 and their contribution to the blood supply in five developed countries: a BEST Collaborative group study | Blood operators | New or improved product or process |
A large national study of ferritin testing in Canadian blood donors | Goldman M, Uzicanin S, Osmond L, Scalia V, O'Brien SF | 2017 | Transfusion | View A large national study of ferritin testing in Canadian blood donors | Blood operators | Clinical research |
Risk of exposure to Zika virus and impact on cord blood banking and adult unrelated donors in hematopoietic cell transplantation: the Canadian Blood Services experience | Adams Z, Morris G, Campbell T, Mostert K, Dibdin N, Fearon M, Elmoazzen H, Mercer D, Young K, Allan D | 2018 | Biol Blood Marrow Transplant | View Risk of exposure to Zika virus and impact on cord blood banking and adult unrelated donors in hematopoietic cell transplantation: the Canadian Blood Services experience | Blood operators | Clinical research |
One step closer': Acceptability of a programme of plasma donation for fractionation from men who have sex with men | Caruso J, Germain M, Godin G, Myhal G, Pronovost P, Morin M, Otis J | 2019 | Vox Sang | View One step closer': Acceptability of a programme of plasma donation for fractionation from men who have sex with men | Blood operators | Other |
Emotional labour and cord blood collection: frontline perspectives | Haw J, Polzer J, Devine Dana V | 2020 | J Health Organ Manag | View Emotional labour and cord blood collection: frontline perspectives | Blood operators | New or improved product or process |
Balancing non-discriminatory donor selection and blood safety in the Netherlands: Evaluation of an individual risk assessment of sexual behavior | Hahn B, Quee F, Prinsze FJ, Gregoire Y, O'Brien SF, Germain M, van de Laar T, Zaaijer HL, van den Hurk K | 2022 | Transfusion | View Balancing non-discriminatory donor selection and blood safety in the Netherlands: Evaluation of an individual risk assessment of sexual behavior | Blood operators | MSM research |
Rapport de surveillance | O'Brien SF | 2022 | Blood.ca website | View Rapport de surveillance | Blood operators | Benchmarking and standard setting |
Adhesion of anaerobic bacteria to platelet containers | Kumaran D, Kalab M, Rood IGH, de Korte D, Ramirez-Arcos S | 2014 | Vox Sang | View Adhesion of anaerobic bacteria to platelet containers | Blood operators | Basic research |
How safe is safe enough, who decides and how? From a zero-risk paradigm to risk-based decision making | Menitove JE, Leach Bennett J, Tomasulo P, Katz LM | 2014 | Transfusion | View How safe is safe enough, who decides and how? From a zero-risk paradigm to risk-based decision making | Blood operators | Other |
Impact of informing donors of low ferritin results | Goldman M, Uzicanin S, Scalia J, Scalia V, O'Brien SF | 2016 | Transfusion | View Impact of informing donors of low ferritin results | Blood operators | Clinical research |
Process improvement by eliminating mixing of whole blood units after an overnight hold prior to component production using the buffy coat method | Mastronardi C, Schubert P, Levin E, Bhakta V, Yi QL, Hansen A, Stewart T, Jenkins C, Lefresne W, Sheffield W, Acker JP | 2013 | J Blood Transfus | View Process improvement by eliminating mixing of whole blood units after an overnight hold prior to component production using the buffy coat method | Blood operators | New or improved product or process |
Characterization of the growth dynamics and biofilm formation of Staphylococcus epidermidis strains isolated from contaminated platelet units | Ali H, Greco-Stewart VS, Jacobs MR, Yomtovian RA, Rood IG, de Korte D, Ramirez-Arcos S | 2014 | J Med Microbiol | View Characterization of the growth dynamics and biofilm formation of Staphylococcus epidermidis strains isolated from contaminated platelet units | Blood operators | Basic research |
Introduction of a closed-system cell processor for red blood cell washing: postimplementation monitoring of safety and efficacy | Acker JP, Hansen AL, Yi Q-L, Sondi N, Cserti-Gazdewich C, Pendergrast J, Hannach B | 2016 | Transfusion | View Introduction of a closed-system cell processor for red blood cell washing: postimplementation monitoring of safety and efficacy | Blood operators | New or improved product or process |
Timing of gamma irradiation and blood donor sex influences in vitro characteristics of red blood cells | de Korte D, Thibault L, Handke W, Harm SK, Morrison A, Fitzpatrick A, Marks DC, Yi QL, Acker JP | 2018 | Transfusion | View Timing of gamma irradiation and blood donor sex influences in vitro characteristics of red blood cells | Blood operators | New or improved product or process |
Donor deferral policies for men who have sex with men: where are we today? | Goldman M, O'Brien SF | 2016 | Curr Opin Hematol | View Donor deferral policies for men who have sex with men: where are we today? | Blood operators | Other |
Experiences with semi-routine production of riboflavin and UV-B pathogen-inactivated platelet concentrates in three blood centres | van der Meer PF, Couture C, Hervig T, Kruit G, Devine DV, de Korte D, Kerkhoffs JL | 2017 | Vox Sang | View Experiences with semi-routine production of riboflavin and UV-B pathogen-inactivated platelet concentrates in three blood centres | Blood operators | New or improved product or process |
Hepatitis E | Petrik J, Lozano M, Seed CR, Faddy HM, Keller AJ, Prado Scuracchio PS, Wendel S, Andonov A, Fearon M, Delage G, Zhang J, Shih JWK, Gallian P, Djoudi R, Tiberghien P, Izopet J, Dreier J, Vollmer T, Knabbe C, Aggarwal R, Goel A, Ciccaglione AR, Matsubayashi K, Satake M, Tadokoro K, Jeong S-H, Zaaijer HL, Zhiburt E, Chay J, Teo D, Chua SS, Piron M, Sauleda S, EchevarrÃa J-M, Dalton H, Stramer SL | 2016 | Vox Sang | View Hepatitis E | Blood operators | Other |